Novellus' Debt - III Round

Novellus raised a round of funding on February 17, 2017.

Novellus Therapeutics was founded to advance therapeutic products based on Factor Bioscience's technologies to the clinic. With a worldwide license to Factor's technologies, Novellus is developing a p…

Articles about Novellus' Debt - III Round: